Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).

Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062). Clin Cancer Res. 1997 May; 3(5):719-25.

View in: PubMed

subject areas

Administration, Oral
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Bone Marrow
Carcinoma, Small Cell
Cisplatin
Disease-Free Survival
Etoposide
Female
Humans
Infusions, Intravenous
Lung Neoplasms
Male
Middle Aged
Neoplasm Staging
Regression Analysis
Time Factors

authors with profiles

Mark J. Ratain
Richard Schilsky